Cancer Research Technology
Log in Register
Menu

Anti-HLADR3, 6, 11, DRJ25 [TAL 8.1]

Invented at Cancer Research UK London Research Institute: Lincoln's Inn Fields

Info

Catalogue Number 151229
Applications ELISA FACS IHC RIA WB
Antigen/Gene or Protein Targets Human Leukocyte Antigens DR3, 6, 11, DRJ25
Reactivity Human
Relevance Human Leukocyte Antigens are highly polymorphic proteins that are involved in the presentation of antigens to the T-cell receptor. There are two classes of HLA antigens, class I (HLA-A, HLA-B and HLA-C) and class II (HLA-D). TAL 8.1 may be used for HLA typing.
Host Mouse
Immunogen Cells from the B line WVB coated with mouse antiserum followed by WVB class II antigen.
Subclass IgG2b
Molecular Weight (kDa) 28
Myeloma Used P3/NS1/1-Ag4.1
Recommended Growing Conditions RPMI 1640 + 10% FCS
Notes TAL 8.1 can detect dimers via western blot and is cytotoxic with rabbit complement.
Research Area Immunology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Bodmer J et al. 1984. Histocompatibility Testing. 432-8. ISBN-13: 978-0387134642


Add a reference

References: 1 entry

Bodmer J et al. 1984. Histocompatibility Testing. 432-8. ISBN-13: 978-0387134642


Add a reference

Inventor Information